Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03875378
PHASE2
Transdermal Estrogen in Women With Anorexia Nervosa
Sponsor: Pouneh K. Fazeli, MD
View on ClinicalTrials.gov
Summary
Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.
Official title: Transdermal Estrogen for the Treatment of Bone Loss in Women With Anorexia Nervosa
Key Details
Gender
FEMALE
Age Range
19 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2020-08-28
Completion Date
2028-12-31
Last Updated
2025-08-07
Healthy Volunteers
No
Conditions
Interventions
DRUG
Transdermal estrogen
Transdermal estradiol (0.045mg)/levonorgestrel (0.015mg) weekly patch
DRUG
Placebos
Placebo weekly patch
Locations (1)
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States